Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00367211 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
A Phase 3 study, sponsored by POZEN.
- Completed
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
NCT00367211 is a Phase 3 study that has completed, run by POZEN. The registered enrollment target is 400 participants.
The verdict
NCT00367211, a Phase 3 study, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the incidence of gastric ulcers following administration of either PN 200 or Naproxen in subjects who are at risk for developing NSAID-associated ulcers.
Interventions
- DRUG PN 200 tablets (500 mg naproxen and 20 mg omeprazole)
- DRUG Naproxen 500 mg tablets (PN 200 minus omeprazole)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00367211
The ClinicalTrials.gov registry entry for NCT00367211 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is POZEN, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PN 200 tablets (500 mg naproxen and 20 mg omeprazole) is the first listed.
NCT00367211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00367211 about?
NCT00367211 is a clinical study titled "Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.". The purpose of this study is to evaluate the incidence of gastric ulcers following administration of either PN 200 or Naproxen in subjects who are at risk for developing NSAID-associated ulcers.
What is the current status of trial NCT00367211?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2006-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00367211?
The interventions under investigation include: PN 200 tablets (500 mg naproxen and 20 mg omeprazole) (DRUG), Naproxen 500 mg tablets (PN 200 minus omeprazole) (DRUG).
Who is sponsoring clinical trial NCT00367211?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.